Fig. 1.

Alluvial plots of distribution of endotype transitions of patients of the SAVE-MORE trial treated with standard-of-care (SoC) and anakinra (left panel) and standard-of-care (SoC) and placebo (right panel), from baseline endotype to the endotype of days 4 and 7 of treatment